June 8, 2021

An estimated 2.4 million Americans have been diagnosed with hepatitis C (HCV). Multiple government entities have joined together, developing a plan to prevent and treat HCV. Overall, 43% of those infected have been in contact with a health care provider, and 16% of patients have received treatment. Of those treated, only 9% have fully recovered....

Complementary and alternative medicine (CAM) usage has been associated with poor adherence to asthma medications. Previous studies showed inconsistent results due to small sample sizes, demographic differences across populations studied, and poor differentiation of CAM types. This study aimed to provide more robust data on the use of CAM by American adults with asthma. The data...

Among American children, it is unclear if the disparity in asthma diagnosis among non-Hispanic white and Latino patients exists as a result of diagnostic variation in clinical scenarios that are suggestive of asthma. This study’s goal was to determine the distribution of demographic factors that correlate with asthma diagnosis within the Hispanic American community. This...

Among American school-aged children, there is a wide variation in asthma outcomes. This study, published in the Journal of Asthma, aimed to provide a national descriptive profile of asthma outcomes among school-aged children (ages 6 – 17). The researchers looked at both asthma control and treatment patterns. The data for this cross-sectional survey came from the...

Razumab is the world’s first biosimilar ranibizumab. It has been approved for treating various types of macular disorders, including wet age-related macular degeneration (AMD). This prospective, multi-center, post-marketing study focuses on the safety and efficacy of biosimilar ranibizumab for patients with wet AMD. The 24-week study enrolled 126 patients with wet AMD. They were all...

The costs of treating wet age-related macular degeneration (AMD) are often very high, both at the individual and societal levels. This study focused on conducting a cost-benefit analysis of wet AMD treatment to understand the economic impact of these treatments. The study specifically compares three types of treatments: intravitreal bevacizumab, ranibizumab, and aflibercept. The study...

Several factors can increase the risk of developing age-related macular degeneration (AMD). This study focused on analyzing the association among IL-8 gene polymorphisms, IL-8 levels, and the risk of developing AMD. The study was conducted as a meta-analysis that relied on IL-8 -251A/T (rs4073) and +781C/T (rs2227306) polymorphisms and IL-8 levels in patients with AMD and...

This study focused on rates of hematologic inflammation in patients with age-related macular degeneration (AMD). Patients with wet AMD and dry AMD were included. The goal of the study was to find correlation patterns between hematologic inflammation and AMD, which could be useful for diagnostic and therapeutic purposes. This study analyzed data from 60 patients...

The World Health Organization (WHO) collects, studies, and develops eye care information for people worldwide. At the 70th World Health Assembly, it was suggested, with the support of experts, that WHO examine the current state of eye care and draw attention to effective strategies to increase patient access to eye care services. Although WHO reports...